Silverarc Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-76,784
| Closed | -$144K | – | 77 |
|
|
2024
Q3 | $144K | Sell |
76,784
-390,613
| -84% | -$734K | 0.03% | 67 |
|
|
2024
Q2 | $921K | Buy |
467,397
+381,014
| +441% | +$751K | 0.22% | 56 |
|
|
2024
Q1 | $265K | Buy |
+86,383
| New | +$265K | 0.07% | 70 |
|
|
2021
Q1 | – | Sell |
-4,856
| Closed | -$552K | – | 99 |
|
|
2020
Q4 | $552K | Buy |
+4,856
| New | +$552K | 0.32% | 67 |
|